# Survey: More than half of Washington clinicians cite mental-health risks from cannabis use > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/mental-health-cannabis-risks-washington-clinicians-survey/ > **Published:** 2026-03-30T18:14:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:08:38-04:00 > **Clinical Summary:** Survey reveals mental health cannabis risks cited by Washington clinicians, highlighting need for nuanced clinical risk assessment. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthClinical EducationRisk AssessmentThc[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) Why This Matters This survey reflects a critical gap between clinical perception and evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). When over half of clinicians cite mental health risks without differentiating between therapeutic use patterns and problematic use, patients lose access to informed care and evidence-based treatment decisions. Clinical Summary A Washington state survey found that more than half of clinicians report concerns about mental health risks from [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). While cannabis can indeed pose mental health risks—particularly with high-THC products, early-onset use, and in vulnerable populations—the clinical picture is nuanced. Evidence shows both therapeutic benefits for conditions like PTSD and anxiety, and risks including [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) and potential psychosis precipitation in susceptible individuals. The survey results likely reflect varying levels of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) education among respondents rather than a comprehensive risk assessment. Dr. Caplan’s Take “This survey tells us more about clinician education gaps than patient risk profiles. We need clinicians who can distinguish between a teenager using high-potency THC daily and a cancer patient using CBD-dominant medicine under medical supervision—these are entirely different clinical scenarios.” Clinical Perspective 🧠 Clinicians should approach cannabis medicine with the same evidence-based framework used for any therapeutic intervention: appropriate patient selection, proper dosing protocols, and monitoring for both efficacy and adverse effects. The key is moving beyond blanket risk statements toward personalized risk-benefit assessments based on individual patient factors, product composition, and usage patterns. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Survey%3A%20More%20than%20half%20of%20Washington%20clinicians%20cite%20mental-health%20risks%20from%20ca...%20%40drcaplan&url=https%3A//komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Survey%3A%20More%20than%20half%20of%20Washington%20clinicians%20cite%20mental-health%20risks%20from%20ca...%20--%20via%20%40drcaplan.bsky.social%20https%3A//komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis](https://komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What are the main clinical areas covered in this cannabis research?](#What_are_the_main_clinical_areas_covered_in_this_cannabis_research) - [Is THC specifically discussed in this clinical update?](#Is_THC_specifically_discussed_in_this_clinical_update) - [Why is this classified as “emerging findings”?](#Why_is_this_classified_as_8220emerging_findings8221) - [Who should pay attention to this cannabis clinical information?](#Who_should_pay_attention_to_this_cannabis_clinical_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, which indicates “Notable Clinical Interest.” This means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. #### What are the main clinical areas covered in this cannabis research? The article covers mental health applications, clinical education aspects, and risk assessment considerations related to [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). These areas are particularly important for healthcare providers treating patients with cannabis-related concerns. #### Is THC specifically discussed in this clinical update? Yes, THC is identified as one of the key topics covered in this clinical education piece. The article likely addresses THC-related clinical considerations for healthcare providers. #### Why is this classified as “emerging findings”? The content is marked as “New” and falls under the category of emerging findings that warrant close monitoring. This suggests the research or policy developments are recent and may impact clinical practice. #### Who should pay attention to this cannabis clinical information? Healthcare providers, particularly those involved in mental health treatment and risk assessment, should monitor this information. The clinical education focus makes it especially relevant for practitioners who may encounter cannabis-related patient cases. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Survey: More than half of Washington clinicians cite mental-health risks from cannabis use”, “url”: “https://komonews.com/news/local/survey-more-than-half-of-washington-clinicians-cite-mental-health-risks-from-cannabis-use-marijuana-weed-drugs-addiction-illness-anxiety-depression-nausea-psychosis-smoking-vaping-edible-medical-healthcare-diagnosis”, “datePublished”: “2026-03-30T20:05:07Z”, “about”: “survey more than half washington clinicians”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [High-potency cannabis linked to mental health risks, expert warns](https://cedclinic.com/high-potency-cannabis-linked-to-mental-health-risks-expert-warns/) Explore expert insights on how high-potency cannabis may increase mental health risks and what clinicians should consider. [Read Expert Warning](https://cedclinic.com/high-potency-cannabis-linked-to-mental-health-risks-expert-warns/) [Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Review research findings that question the effectiveness of cannabis for treating depression, anxiety, and PTSD. [Explore Research](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) [Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed … Learn how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) advances clinical understanding and supports informed health decisions. Discover More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).